• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke-A retrospective cohort study

tetano

Editor, Senior Moderator
PLoS One


. 2023 Mar 2;18(3):e0282045.
doi: 10.1371/journal.pone.0282045. eCollection 2023.
The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke-A retrospective cohort study


Tímea Tünde Takács[SUP] 1 2 [/SUP], Ádám József Berki[SUP] 1 2 [/SUP], Péter Pál Böjti[SUP] 1 2 3 [/SUP], Rita Stang[SUP] 1 2 [/SUP], Pablo Antonio Fritz-Reunes[SUP] 1 [/SUP], Luiz Schnekenberg[SUP] 4 [/SUP], Timo Siepmann[SUP] 4 5 [/SUP], Alexandra Pintér[SUP] 5 6 [/SUP], Szabolcs Szatmári[SUP] 1 7 [/SUP], Dániel Bereczki[SUP] 1 7 8 [/SUP], Bence Gunda[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Acute ischemic stroke (AIS) is a common complication of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection (COVID-19), but the prognosis of these patients is poorly understood.
Purpose: To explore the impact of COVID-19 on neurological outcomes in AIS patients.
Methods: A comparative retrospective cohort study was conducted in 32 consecutive AIS patients with and 51 without COVID-19 between the 1st of March 2020 and 1st of May 2021. The evaluation was based on a detailed chart review for demographic data, medical history, stroke severity, cranial and vessel imaging results, laboratory parameters, COVID-19 severity, hospitalization time, in-hospital mortality, and functional deficits at discharge (modified Rankin Scale, mRS).
Results: COVID-19 AIS patients showed tendency to worse initial neurological deficit (NIHSS 9 (3-13) vs. 4 (2-10); p = 0.06), higher rate of large vessel occlusion (LVO; 13/32 vs. 14/51; p = 0.21), had prolonged hospitalization (19.4 ± 17.7 vs. 9.7 ± 7 days; p = 0.003), had lower chance of functional independence (mRS≤2) (12/32 vs. 32/51; p = 0.02) and showed higher in-hospital mortality (10/32 vs. 6/51; p = 0.02). In COVID-19 AIS patients, LVO was more common with COVID-19 pneumonia than without (55.6% vs. 23.1%; p = 0.139).
Conclusion: COVID-19-related AIS carries a worse prognosis. COVID-19 with pneumonia seems to be associated with a higher rate of LVO.
 
Back
Top Bottom